BIOSOURCE INTERNATIONAL INC

Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

Signs

● 1 severe● 0 good

Filed a late-filing notice (Form NT) — missed an SEC deadline

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

NT 10-Q/Amissed a reporting deadline ↗May 17, 2005
NT 10-Qmissed a reporting deadline ↗May 16, 2005
NT 10-Kmissed a reporting deadline ↗Apr 1, 1999
NT 10-Kmissed a reporting deadline ↗Mar 28, 1997

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

SC 13G/AAMENDED 13G FOR BIOSOURCE INTERNATIONAL INCFeb 14, 2006
SC 13G/AAMENDMENT NO. 1 TO SCHEDULE 13GFeb 14, 2006
SC 13D/AOct 12, 2005
15-12GOct 7, 2005
SC 13D/ASep 22, 2005
DEFM14ASep 7, 2005
SC 13DAug 23, 2005
PREM14AAug 10, 2005
SC 13DSCHEDULE 13DAug 4, 2005
10-QAug 2, 2005
SC 13D/AJul 29, 2005
DEFA14AJul 27, 2005
8-KJul 26, 2005
UPLOADJul 8, 2005
CORRESPJun 30, 2005

Event-driven situations (1)

Sep 7, 2005Merger / acquisition (shareholder vote)completed

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.